The Chennai facility will manufacture high-quality medical tubing for neurovascular and cardiovascular applications, including balloon catheters and other minimally invasive devices
Granules India has reported total income of Rs. 1,384.29 crore during the period ended December 31, 2025
Company to launch product after the expiry of semaglutide patent in India
The product delivers 100 percent of the Recommended Dietary Allowance (RDA) of three essential nutrients—Biotin, Vitamin C and Zinc
This innovation enhances viral stability, preserves potency, and reduces allergic reactions and antigen crystallisation-related issues
The collaboration will focus on enhancing surgeon capabilities, developing structured training pathways, and promoting the adoption of robotic-assisted surgery in both routine and complex procedures
India in the Changing Landscape of Life-Sciences Research & Development
Sabitha highlighted the growing relevance of minimally invasive therapies in modern medicine
DengiAll will be the first indigenous single-shot dengue vaccine in India and is expected to enter the markets by 2027
Subscribe To Our Newsletter & Stay Updated
